Back to Delaware

HS1FORHB200 • 2025

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE FOR TREATMENT TO PREVENT HIV INFECTION.

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE FOR TREATMENT TO PREVENT HIV INFECTION.

Labor
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Chukwuocha
Last action
2026-04-22
Official status
Out of Committee 4/22/26
Effective date
Not listed

Plain English Breakdown

The official source material does not provide specific details on how the act updates section numbers or applicability dates for insurance companies' rate adjustments.

Act to Require Insurance Coverage for HIV Prevention Medication

This act requires health insurance plans, group plans, state employee health plans, and Medicaid to cover PrEP (pre-exposure prophylaxis) and PEP (post-exposure prophylaxis) medication without cost-sharing or delays.

What This Bill Does

  • Requires individual and group health insurance policies to cover medically necessary PrEP and PEP medications for HIV prevention.
  • Prohibits any cost-sharing requirements, prior authorization steps, or unreasonable delays in providing coverage for these medications.
  • Applies the requirement to state employee health plans and Medicaid as well.

Who It Names or Affects

  • People with individual or group health insurance policies.
  • State employees covered by the state's health plan.
  • Individuals receiving Medicaid benefits.

Terms To Know

PrEP
Medication taken before possible HIV exposure to prevent infection.
PEP
Medication taken after possible HIV exposure to prevent infection.

Limits and Unknowns

  • The act does not apply to accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, disability income, or other limited health insurance policies.
  • Coverage requirements start for policies renewed, modified, altered, amended, or reissued after December 31, 2027.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HA 1

1 • Chukwuocha

Passed 3/26/26

Plain English: This amendment makes technical changes to a bill about insurance coverage for HIV prevention treatment, including reorganizing paragraphs and clarifying certain terms.

  • Reorganized paragraph structure in Sections 1 and 2 of the bill to match other health coverage rules.
  • Changed 'individual' to 'group and blanket' policies in Section 2 to include more types of insurance plans.
  • Removed a rule about catastrophic plans not sharing costs, since these are individual plans.
  • Added that all health benefit plans must cover HIV prevention treatment if they are issued under certain sections.
  • The amendment text does not explain the full impact of each change in simple terms, so some details might be unclear.

Bill History

  1. 2026-04-22 Delaware General Assembly

    Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits

  2. 2026-03-26 Delaware General Assembly

    Amendment HA 1 to HS 1 - Passed In House by Voice Vote

  3. 2026-03-26 Delaware General Assembly

    Passed By House. Votes: 39 YES 1 NOT VOTING 1 ABSENT

  4. 2026-03-26 Delaware General Assembly

    Assigned to Banking, Business, Insurance & Technology Committee in Senate

  5. 2026-03-17 Delaware General Assembly

    Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 2 Favorable, 8 On Its Merits

  6. 2026-03-17 Delaware General Assembly

    Amendment HA 1 to HS 1 - Introduced and Placed With Bill

  7. 2026-01-08 Delaware General Assembly

    Adopted in lieu of the original bill HB 200, and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Official Summary Text

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE FOR TREATMENT TO PREVENT HIV INFECTION.
This Act is a substitute for HB 200 and differs from HB 200 by requiring health insurance coverage only for pre-exposure prophylaxis (“PrEP”) medication and post-exposure prophylaxis (“PEP”) medication. This Act also makes technical corrections including updating section numbers and updating the applicability date so insurance companies can file rates that include the cost of the coverage required under this Act.

This Act requires individual health insurance plans, group and blanket health insurance plans, the state employee health plan, and state Medicaid insurance to cover medically necessary PrEP medication for the prevention of human immunodeficiency virus (“HIV”) infection before possible HIV exposure and medically necessary PEP medication for the prevention of HIV infection after possible HIV exposure.

The coverage must include must be provided without any of the following:
1. Cost-sharing requirements, including deductibles, coinsurance, copayments, and out-of-pocket expenses.
2. Prior authorization or step therapy requirements.
3. Unreasonable delay in coverage determination.

This Act applies to all policies, contracts, or certificates that are renewed, modified, altered, amended, or reissued after December 31, 2027.

Current Bill Text

Read the full stored bill text
Legislation Document

SPONSOR:

Rep. Chukwuocha & Sen. Pinkney & Rep. Morrison & Rep. Neal

Reps. Griffith, K. Johnson, Berry, Carson, Lambert, Ross Levin, Gorman, Bolden, Romer, Harris

HOUSE OF REPRESENTATIVES

153rd GENERAL ASSEMBLY

HOUSE SUBSTITUTE NO. 1

FOR

HOUSE BILL NO. 200

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE FOR TREATMENT TO PREVENT HIV INFECTION.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Section 1. Amend Chapter 33, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 3370N. Coverage for pre-exposure prophylaxis treatment and post-exposure prophylaxis treatment.

(a) As used in this section:

(1) “Cost-sharing requirement” includes a deductible, coinsurance, copayment, and out-of-pocket expense.

(2) “HIV” means the human immunodeficiency virus.

(3) “Medically necessary” includes prescribing PrEP and PEP to individuals who are at increased risk of HIV acquisition.

(4) “PEP” means post-exposure prophylaxis medication for preventing HIV infection after possible HIV exposure.

(5) “PrEP” means pre-exposure prophylaxis medication for preventing HIV infection before possible HIV exposure.

(b)(1) All individual health insurance policies, contracts, or certificates that are delivered, issued for delivery,

renewed, extended, or modified in this State must provide coverage for all of the following:

a. Medically necessary PrEP.

b. Medically necessary PEP.

(2) The coverage required under paragraph (b)(1) of this section must be provided without any of the following:

a. Cost-sharing requirements.

b. Prior authorization or step therapy requirements.

c. Unreasonable delay in coverage determination.

(c) Except as otherwise provided in subsection (b) of this section, nothing in this section prevents the operation of a policy provision required by this section as a deductible, coinsurance, allowable charge limitation, coordination of benefits, or a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility.

(d) This section does not apply to accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, disability income, or other limited health insurance policies.

(e)(1) The cost-sharing limitation under paragraph (b)(2) of this section does not apply to a catastrophic health

plan to the extent this cost-sharing limitation would cause the plan to fail to be treated as a catastrophic health plan under § 1302(e) of the Patient Protection and Affordable Care Act, 42 U.S.C. § 18022(e).

(2)a. The cost-sharing limitation under paragraph (b)(2) of this section does not apply to a high deductible health plan to the extent this cost-sharing limitation would cause the plan to fail to be treated as a high deductible

health plan under § 223(c)(2) of the Internal Revenue Code.

b. If the cost-sharing limitation under paragraph (b)(2) of this section would result in an enrollee becoming ineligible for a health savings account under federal law, the cost-sharing limitation only applies to a qualified high deductible plan after the enrollee’s deductible has been met.

Section 2. Amend Chapter 35, Title 18 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 3571FF. Coverage for pre-exposure prophylaxis treatment and post-exposure prophylaxis treatment.

(a) As used in this section:

(1) “Cost-sharing requirement” includes a deductible, coinsurance, copayment, and out-of-pocket expense.

(2) “HIV” means the human immunodeficiency virus.

(3) “Medically necessary” includes prescribing PrEP and PEP to individuals who are at increased risk of HIV acquisition.

(4) “PEP” means post-exposure prophylaxis medication for preventing HIV infection after possible HIV exposure.

(5) “PrEP” means pre-exposure prophylaxis medication for preventing HIV infection before possible HIV exposure.

(b)(1) All individual health insurance policies, contracts, or certificates that are delivered, issued for delivery,

renewed, extended, or modified in this State must provide coverage

for all of the following:

a. Medically necessary PrEP.

b. Medically necessary PEP.

(2) The coverage required under paragraph (b)(1) of this section must be provided without any of the following:

a. Cost-sharing requirements.

b. Prior authorization or step therapy requirements.

c. Unreasonable delay in coverage determination.

(c) Except as otherwise provided in subsection (b) of this section, nothing in this section prevents the operation of a policy provision required by this section as a deductible, coinsurance, allowable charge limitation, coordination of benefits, or a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility.

(d) This section does not apply to accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, disability income, or other limited health insurance policies.

(e)(1) The cost-sharing limitation under paragraph (b)(2) of this section does not apply to a catastrophic health

plan to the extent this cost-sharing limitation would cause the plan to fail to be treated as a catastrophic health plan under § 1302(e) of the Patient Protection and Affordable Care Act, 42 U.S.C. § 18022(e).

(2)a. The cost-sharing limitation under paragraph (b)(2) of this section does not apply to a high deductible health plan to the extent this cost-sharing limitation would cause the plan to fail to be treated as a high deductible

health plan under § 223(c)(2) of the Internal Revenue Code.

b. If the cost-sharing limitation under paragraph (b)(2) of this section would result in an enrollee becoming ineligible for a health savings account under federal law, the cost-sharing limitation only applies to a qualified high deductible plan after the enrollee’s deductible has been met.

Section 3. Amend Chapter 52, Title 29 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 5224. Coverage for pre-exposure prophylaxis treatment and post-exposure prophylaxis treatment.

(a) As used in this section:

(1) “Cost-sharing requirement” includes a deductible, coinsurance, copayment, and out-of-pocket expense.

(2) “HIV” means the human immunodeficiency virus.

(3) “Medically necessary” includes prescribing PrEP and PEP to individuals who are at increased risk of HIV acquisition.

(4) “PEP” means post-exposure prophylaxis medication for preventing HIV infection after possible HIV exposure.

(5) “PrEP” means pre-exposure prophylaxis medication for preventing HIV infection before possible HIV exposure.

(b)(1)

The plan must provide coverage

for all of the following:

a. Medically necessary PrEP.

b. Medically necessary PEP.

(2) The coverage required under paragraph (b)(1) of this section must be provided without any of the following:

a. Cost-sharing requirements.

b. Prior authorization or step therapy requirements.

c. Unreasonable delay in coverage determination.

Section 4. Amend Chapter 5, Title 31 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§

539.

Coverage

for

pre-exposure

prophylaxis

treatment

and

post-exposure

prophylaxis

treatment.

(a)

As

used

in

this

section:

(1) “Cost-sharing requirement”

includes

a

deductible,

coinsurance,

copayment,

and

out-of-pocket

expense.

(2) “HIV”

means

the

human

immunodeficiency

virus.

(3) “Medically necessary” includes prescribing PrEP and PEP to individuals who are at increased risk of HIV

acquisition.

(4) “PEP”

means

post-exposure

prophylaxis

medication

for

preventing

HIV

infection

after

possible

HIV

exposure.

(5) “PrEP”

means

pre-exposure

prophylaxis

medication

for

preventing

HIV

infection

before

possible

HIV

exposure.

(b)(1) Carriers shall provide coverage

for all of the following:

a. Medically necessary PrEP.

b. Medically necessary PEP.

(2) To the extent permitted by federal law, the coverage required under paragraph (b)(1) of this section must be provided without any of the following:

a. Cost-sharing

requirements.

b. Prior

authorization or

step therapy

requirements.

c. Unreasonable

delay in coverage

determination.

Section 5. This Act applies to all policies, contracts, or certificates that are renewed, modified, altered, amended,

or reissued after December 31, 2027.

SYNOPSIS

This Act is a substitute for HB 200 and differs from HB 200 by requiring health insurance coverage only for pre-exposure prophylaxis (“PrEP”) medication and post-exposure prophylaxis (“PEP”) medication. This Act also makes technical corrections including updating section numbers and updating the applicability date so insurance companies can file rates that include the cost of the coverage required under this Act.

This Act requires individual health insurance plans, group and blanket health insurance plans, the state employee health plan, and state Medicaid insurance to cover medically necessary PrEP medication for the prevention of human immunodeficiency virus (“HIV”) infection before possible HIV exposure and medically necessary PEP medication for the prevention of HIV infection after possible HIV exposure.

The coverage must include must be provided without any of the following:

1. Cost-sharing requirements, including deductibles, coinsurance, copayments, and out-of-pocket expenses.

2. Prior authorization or step therapy requirements.

3. Unreasonable delay in coverage determination.

This Act applies to all policies, contracts, or certificates that are renewed, modified, altered, amended, or reissued after December 31, 2027.